[1]
“Retrospective Clinical Evidence on Switching to Modern Sulfonylurea/Metformin in Patients Uncontrolled on DPP4i-based Therapies”, AJD, vol. 24, no. 4, pp. 9–17, Oct. 2024, doi: 10.59793/hjthw688.